Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of CJ-12420 and Clarithromycin
NCT02052336Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan in gastroesophageal reflux disease (GERD) and gastric ulcer (3 arms), sponsored by HK inno.N Corporation. Primary endpoint: Pharmacokinetics of CJ-12420 or Clarithromycin at 24 hours. Started Oct 2013; status: completed.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)gastric ulcer
Beyond the preview
Go deeper on NCT02052336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052336.